JAGSNPHARM Intraday Analysis...

JAGSNPHARM Share Price

Open 37.70 Change Price %
High 38.90 1 Day -0.05 -0.13
Low 37.70 1 Week -2.70 -6.64
Close 37.95 1 Month -1.80 -4.53
Volume 11188 1 Year 1.35 3.69
52 Week High 46.95
52 Week Low 25.80
JAGSNPHARM Important Levels
Resistance 2 39.06
Resistance 1 38.60
Pivot 38.18
Support 1 37.30
Support 2 36.84
NSE INDIA Most Active Stocks
SREINFRA 86.00 -3.32%
JPASSOCIAT 13.40 0.37%
SUZLON 18.90 -0.53%
IDEA 90.90 -0.76%
SIGNET 16.45 0.00%
BANKBARODA 169.05 4.22%
UNITECH 5.75 0.88%
SBIN 276.50 2.98%
PNB 141.50 4.16%
ICICIBANK 274.75 2.92%
More..
NSE INDIA Top Gainers Stocks
RASOYPR 0.20 33.33%
ATNINTER 0.25 25.00%
AUSTRAL 0.30 20.00%
FCSSOFT 0.30 20.00%
STARPAPER 171.05 19.99%
CIMMCO 89.15 19.99%
BALKRISHNA 84.20 19.86%
GTNTEX 17.35 19.66%
LGBFORGE 7.35 18.55%
SMPL 2.25 18.42%
More..
NSE INDIA Top Losers Stocks
POLYMED 246.95 -54.63%
VKSPL 0.05 -50.00%
FARMAXIND 0.05 -50.00%
NAKODA 0.35 -12.50%
VIPULLTD 60.10 -12.20%
REFEX 23.20 -9.90%
MVL 0.50 -9.09%
MVL 0.50 -9.09%
NLCINDIA 109.80 -8.84%
ZENITHBIR 0.55 -8.33%
More..

Jagsonpal Pharmaceuticals Limited (NSE: JAGSNPHARM)

JAGSNPHARM Technical Analysis 1.5
As on 24th Mar 2017 JAGSNPHARM Share Price closed @ 37.95 and we RECOMMEND Buy for LONG-TERM with Stoploss of 37.38 & Sell for SHORT-TERM with Stoploss of 38.46 we also expect STOCK to react on Following IMPORTANT LEVELS.
JAGSNPHARM Target for March
1st Target up-side 43.27
2nd Target up-side 46.65
3rd Target up-side 50.03
1st Target down-side 33.63
2nd Target down-side 30.25
3rd Target down-side 26.87
Jagsonpal Pharmaceuticals Limited ( NSE INDIA Symbol : JAGSNPHARM )
Sector : Pharmaceuticals - Formulations And Other Stocks in Same Sector
JAGSNPHARM
37.95 -0.05 (-0.13 %)
LT : Buy
ST : Sell
AMRUTANJAN
561.35 2.20 (0.39 %)
LT : Buy
ST : Sell
JAGSNPHARM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 45.63 Sideways
MFI (14) MFI is 75.43 Sideways
CCI (20) CCI is -59.98 Sideways
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is 15.55 Range Bound
PSAR Stoploss For Short Sell 44.13
10 Day Avg Volume Traded -85.65 % Less then 10 Day Average Volume
JAGSNPHARM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals - Formulations
Industry
Offical website
JAGSNPHARM Address
JAGSNPHARM
N/A
Interactive Technical Analysis Chart Jagsonpal Pharmaceuticals Limited ( JAGSNPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Jagsonpal Pharmaceuticals Limited
JAGSNPHARM Business Profile
Jagson Pharma is in the Pharmaceuticals - Formulations sector. Jagsonpal Pharmaceuticals (JAGSONPH) is a pharmaceutical company producing drugs and formulations. The company was incorporated in 1978 as a private limited company and went public in 1986. The company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. It focuses on several therapeutic groups like anti-arthritics, anti-inflammatories, analgesics, anti-spasmodics, progesterones, anabolic steroids, anesthetics and anti-fungals. Top selling brands include Lycored, Maintane, Metadec, Metabol, Doxypal DR, Parvon, and Indocap SR. The company manufactures active pharmaceutical ingredients (APIs) like Allylestrenol, Disulfiram, Tolnaftate, ..etc. The bulk drug range includes dextropropoxyphene HCl, tolnaftate, dextropropoxyphene napsylate and thiopental sodium. The manufacturing facility in Delhi is WHO and GMP-certified for the production of various dosage forms and bulk drugs and intermediates. The company also maintains a number of dedicated contract manufacturing facilities around the globe. It has an expanding international portfolio of affiliates, joint ventures and representative offices across the globe. The distribution network in India is comprised of over 1,500 authorized stockists who are serviced by depots. The products are retailed at over 125,000 pharmacies. The company is represented by 2,500 agents worldwide and has offices in three continents. The company`s operations span Russia, USA, Brazil, Ukraine, Sri Lanka, Cameroon, Argentina, Thailand, Germany, Switzerland, Korea, Egypt and Vietnam. The company has a sales office in New York through which it services North and Latin American clients and in Belarus, it has an operation center with a sales and distribution team. The current market capitalisation stands at Rs 23.71 crore.The company has reported a standalone sales of Rs 36.79 crore and a Net Profit of Rs 0.01 crore for the quarter ended Sep 2013. The company management includes R P S Kochhar - Chairman & Managing Director, S K Goyal - Director, Govind Deo - Additional Director, Bharat Sinh - Additional Director, Ishpal Singh Ghai - Additional Director. It is listed on the BSE with a BSE Code of 507789 and the NSE with an NSE Code of JAGSNPHARM. Its Registered office is at T-210 J, Shahpur Jat , New Delhi,Delhi - 110049.